{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:14:23Z","timestamp":1773746063654,"version":"3.50.1"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060498","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T03:24:53Z","timestamp":1365045893000},"page":"e60498","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Engineering Agatoxin, a Cystine-Knot Peptide from Spider Venom, as a Molecular Probe for In Vivo Tumor Imaging"],"prefix":"10.1371","volume":"8","author":[{"given":"Sarah J.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheuk Lun","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi K.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2310\/7290.2011.00003","article-title":"Techniques for molecular imaging probe design","volume":"10","author":"F Reynolds","year":"2011","journal-title":"Mol Imaging"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/156802610791384225","article-title":"Design and development of molecular imaging probes","volume":"10","author":"K Chen","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BA20080287","article-title":"Engineered affinity proteins for tumour-targeting applications","volume":"53","author":"M Friedman","year":"2009","journal-title":"Biotechnol Appl Biochem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","article-title":"Pharmacokinetics and biodistribution of genetically engineered antibodies","volume":"13","author":"SK Batra","year":"2002","journal-title":"Curr Opin Biotechnol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cbpa.2011.02.008","article-title":"Bioactive cystine knot proteins","volume":"15","author":"NL Daly","year":"2011","journal-title":"Curr Opin Chem Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.2174\/138161211798999465","article-title":"Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications","volume":"17","author":"H Kolmar","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ddtec.2011.07.003","article-title":"Knottins: Disulfide-bonded therapeutic and diagnostic peptides","volume":"9","author":"SJ Moore","year":"2011","journal-title":"Drug Discovery Today: Technologies"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/pro.5560031022","article-title":"A common structural motif incorporating a cystine knot and a triple-stranded beta-sheet in toxic and inhibitory polypeptides","volume":"3","author":"PK Pallaghy","year":"1994","journal-title":"Protein Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1021\/bi049711q","article-title":"Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot","volume":"43","author":"ML Colgrave","year":"2004","journal-title":"Biochemistry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10611860600648254","article-title":"The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery","volume":"14","author":"M Werle","year":"2006","journal-title":"J Drug Target"},{"key":"ref11","article-title":"Protein scaffold-based molecular probes for cancer molecular imaging","volume":"12","author":"Z Miao","year":"2010","journal-title":"Amino Acids epub Feb"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"12533","DOI":"10.3390\/molecules171112533","article-title":"Chemical Synthesis, Backbone Cyclization and Oxidative Folding of Cystine-knot Peptides; Promising Scaffolds for Applications in Drug Design","volume":"17","author":"M Reinwarth","year":"2012","journal-title":"Molecules"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1096\/fj.02-1044fje","article-title":"Evolutionary origin of inhibitor cystine knot peptides","volume":"17","author":"S Zhu","year":"2003","journal-title":"FASEB J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"D314","DOI":"10.1093\/nar\/gkm939","article-title":"KNOTTIN: the knottin or inhibitor cystine knot scaffold in 2007","volume":"36","author":"J Gracy","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/14656566.9.9.1575","article-title":"Ziconotide: an update and review","volume":"9","author":"JA Williams","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"M Veiseh","year":"2007","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/17460441.2012.661554","article-title":"Cyclotides as a basis for drug design","volume":"7","author":"DJ Craik","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1586\/erm.10.15","article-title":"Engineered cystine-knot miniproteins for diagnostic applications","volume":"10","author":"H Kolmar","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-396962-0.00009-4","article-title":"Engineering knottins as novel binding agents","volume":"503","author":"SJ Moore","year":"2012","journal-title":"Methods in Enzymology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/cb200039s","article-title":"Protease-resistant peptide ligands from a knottin scaffold library","volume":"6","author":"JA Getz","year":"2011","journal-title":"ACS Chem Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1399-3011.1989.tb00210.x","article-title":"Protease inhibitors from <italic>Ecballium elaterium<\/italic> seeds","volume":"33","author":"A Favel","year":"1989","journal-title":"Int J Pept Protein Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0300-9084(90)90067-Q","article-title":"Molecular recognition between serine proteases and new bioactive microproteins with a knotted structure","volume":"72","author":"D Le Nguyen","year":"1990","journal-title":"Biochimie"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"MM Ollmann","year":"1997","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1021\/bi012000x","article-title":"Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity","volume":"41","author":"PJ Jackson","year":"2002","journal-title":"Biochemistry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1006\/jmbi.1999.3383","article-title":"Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif","volume":"294","author":"DJ Craik","year":"1999","journal-title":"J Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/prot.22441","article-title":"Engineered cystine knot peptides that bind alphav beta3, alphav beta5, and alpha5 beta1 integrins with low-nanomolar affinity","volume":"77","author":"RH Kimura","year":"2009","journal-title":"Proteins"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jmb.2008.11.004","article-title":"Engineered cystine-knot peptides that bind alphav beta3 integrin with antibody-like affinities","volume":"385","author":"AP Silverman","year":"2009","journal-title":"J Mol Biol"},{"key":"ref28","article-title":"A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging","author":"H Jiang","year":"2012","journal-title":"Amino Acids"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2967\/jnumed.109.069831","article-title":"Evaluation of a <sup>64<\/sup>Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphav beta3 integrin","volume":"51","author":"L Jiang","year":"2010","journal-title":"J Nucl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-08-2495","article-title":"Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects","volume":"69","author":"RH Kimura","year":"2009","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/bc9003102","article-title":"A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects","volume":"21","author":"RH Kimura","year":"2010","journal-title":"Bioconjug Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7150\/thno\/v01p0403","article-title":"PET imaging of integrin positive tumors using <sup>18<\/sup>F-labeled knottin peptides","volume":"1","author":"S Liu","year":"2012","journal-title":"Theranostics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/bc900361g","article-title":"An engineered knottin peptide labeled with <sup>18<\/sup>F for PET imaging of integrin expression","volume":"20","author":"Z Miao","year":"2009","journal-title":"Bioconjug Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1158\/0008-5472.CAN-10-1338","article-title":"PET imaging of tumor neovascularization in a transgenic mouse model with a novel <sup>64<\/sup>Cu-DOTA-knottin peptide","volume":"70","author":"CH Nielsen","year":"2010","journal-title":"Cancer Res"},{"key":"ref35","article-title":"<sup>111<\/sup>In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis","author":"L Jiang","year":"2012","journal-title":"J Biomed Biotechnol 2012"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2967\/jnumed.109.068007","article-title":"Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides","volume":"51","author":"JK Willmann","year":"2010","journal-title":"J Nucl Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"PC Brooks","year":"1994","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9440(10)65005-5","article-title":"Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin","volume":"156","author":"S Kim","year":"2000","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"PC Brooks","year":"1994","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","article-title":"Definition of two angiogenic pathways by distinct alpha v integrins","volume":"270","author":"M Friedlander","year":"1995","journal-title":"Science"},{"key":"ref41","article-title":"Molecular imaging of avb3 expression in cancer patients","author":"FC Gaertner","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/1535-7163.MCT-06-0395","article-title":"How molecular imaging is speeding up antiangiogenic drug development","volume":"5","author":"W Cai","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2004.02.007","article-title":"Tarantulas: eight-legged pharmacists and combinatorial chemists","volume":"43","author":"P Escoubas","year":"2004","journal-title":"Toxicon"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2164-10-375","article-title":"ArachnoServer: a database of protein toxins from spiders","volume":"10","author":"DL Wood","year":"2009","journal-title":"BMC Genomics"},{"key":"ref45","first-page":"681","article-title":"Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels","volume":"44","author":"ME Adams","year":"1993","journal-title":"Mol Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/jmbi.1995.0406","article-title":"Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers","volume":"250","author":"JI Kim","year":"1995","journal-title":"J Mol Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0040-4039(00)99954-4","article-title":"Coversion of NG-urethane protected arginine to ornithine in peptide solid phase synthesis","volume":"25","author":"H Rink","year":"1984","journal-title":"Tetrahedron Letters"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02759162","article-title":"The solid-phase synthesis of peptides containing an arginine residue with an unprotected guanidine group","volume":"26","author":"A Rubina","year":"2000","journal-title":"Russian Journal of Bioorganic Chemistry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/nar\/gki524","article-title":"TM-align: a protein structure alignment algorithm based on the TM-score","volume":"33","author":"Y Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1083\/jcb.127.4.1129","article-title":"Integrin alphav beta3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha5 beta1","volume":"127","author":"SD Blystone","year":"1994","journal-title":"J Cell Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1046\/j.1538-7836.2003.00277.x","article-title":"Integrins, cations and ligands: making the connection","volume":"1","author":"JP Xiong","year":"2003","journal-title":"J Thromb Haemost"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/anie.199713741","article-title":"Stereoisomeric peptide libaries and peptidomimetics for designing selective inhibitors of the avb3 integrin for a new cancer therapy","volume":"36","author":"R Haubner","year":"1997","journal-title":"Angew Chem Int Ed"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/02648725.2010.10648145","article-title":"Phage display and molecular imaging: expanding fields of vision in living subjects","volume":"27","author":"FV Cochran","year":"2010","journal-title":"Biotechnology and Genetic Engineering Reviews"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jmb.2004.12.030","article-title":"Structures of the agouti signaling protein","volume":"346","author":"JC McNulty","year":"2005","journal-title":"J Mol Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00259-006-0136-0","article-title":"Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?","volume":"33","author":"R Haubner","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10555-008-9158-3","article-title":"Imaging of integrin alphavbeta3 expression","volume":"27","author":"AJ Beer","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/0008-5472.CAN-09-2724","article-title":"Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size","volume":"70","author":"C Zahnd","year":"2010","journal-title":"Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"A Orlova","year":"2006","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","article-title":"A modeling analysis of the effects of molecular size and binding affinity on tumor targeting","volume":"8","author":"MM Schmidt","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-396962-0.00010-0","article-title":"Practical theoretic guidance for the design of tumor-targeting agents","volume":"503","author":"KD Wittrup","year":"2012","journal-title":"Methods Enzymol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiol.12111504","article-title":"Use of <sup>64<\/sup>Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging","volume":"263","author":"BJ Hackel","year":"2012","journal-title":"Radiology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2011.10.017","article-title":"Recent trends in antibody-based oncologic imaging","volume":"315","author":"S Kaur","year":"2012","journal-title":"Cancer Lett"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.febslet.2010.04.014","article-title":"Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications","volume":"584","author":"J Lofblom","year":"2010","journal-title":"FEBS Lett"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PPO.0b013e31817b07ae","article-title":"Antibodies for molecular imaging of cancer","volume":"14","author":"AM Wu","year":"2008","journal-title":"Cancer J"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.addr.2008.04.005","article-title":"Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins","volume":"60","author":"H Akizawa","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","article-title":"Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention","volume":"51","author":"E Vegt","year":"2010","journal-title":"J Nucl Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-11-1116","article-title":"Pharmacokinetically stabilized cystine knot peptides that bind alphav beta6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer","volume":"18","author":"RH Kimura","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/protein\/gzs036","article-title":"Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution","volume":"25","author":"BJ Hackel","year":"2012","journal-title":"Protein Eng Des Sel"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0041-0101(94)00186-C","article-title":"Immunogenicity of a disulphide-containing neurotoxin: presentation to T-cells requires a reduction step","volume":"33","author":"B Maillere","year":"1995","journal-title":"Toxicon"},{"key":"ref70","first-page":"113","article-title":"Quantitative PET imaging of tumor integrin alphav beta3 expression with <sup>18<\/sup>F-FRGD2","volume":"47","author":"X Zhang","year":"2006","journal-title":"J Nucl Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:59:01Z","timestamp":1562875141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060498"}},"subtitle":[],"editor":[{"given":"Matthew","family":"Bogyo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060498","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}